A phase II study of sitravatinib (Sitra) in combination with nivolumab (Nivo) in patients (Pts) undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (accRCC).
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jose A. Karam, Pavlos Msaouel, Surena F. Matin, Matthew T Campbell, Amado J. Zurita, Amishi Yogesh Shah, Ignacio Ivan Wistuba, Cara L. Haymaker, Enrica Marmonti, Dzifa Yawa Duose, Edwin R. Parra, Luisa Maren Solis, Caddie Laberiano, Marisa Lozano, Alice Abraham, Max Hallin, Peter Olson, Hirak Der-Torossian, Nizar M. Tannir, Christopher G. Wood
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Mirati Therapeutics
OpenAlex ID: W3133786991